Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early‐ to Mid‐Stage Parkinson's Disease Modification Trials

Documenti analoghi

• Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy
  di: Nirosen Vijiaratnam, et al.
  Pubblicazione: (2025)
• Levodopa Efficacy and GLP ‐1 Receptor Agonists
  di: Catherine Martinez, et al.
  Pubblicazione: (2026)
• Ambroxol for Parkinson's Disease
  di: Marco Toffoli, et al.
  Pubblicazione: (2026)
• A Symmetric Regressor for MRI-Based Assessment of Striatal Dopamine Transporter Uptake in Parkinson's Disease With Enhanced Uncertainty Estimation
  di: Al, Walid Abdullah, et al.
  Pubblicazione: (2024)
• Effect of Dopamine in Enhancement of SNR of Cortico-Striatal-Thalamo-Cortical Loop Spiking
  di: Barati, Hadi, et al.
  Pubblicazione: (2025)